NIH-funded research R21 grant

Specialized lipid-based medicines to protect against radiation effects

Official title: Specialized Pro-Resolving Lipid Mediators for Systemic Radiation Countermeasures

Funded at Albany Medical College · NIH-11385511 · Data updated 2026-11-12

A patient-friendly look at a study testing lipid mediators that may help people exposed to radiation feel better and recover faster.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionAlbany Medical College
NIH-funded
Lab location1 site (Albany, United States)
Project startAugust 5, 2025
Project endJuly 31, 2027
Funding year2026
Award (this year)$164,000
NIH project number5R21AI193882-02
Project IDNIH-11385511 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals at risk of or recently exposed to radiation in scenarios like accidents, occupational exposure, or other nuclear incidents, where protective or therapeutic strategies are needed.

Less likely to help

People without radiation exposure or with conditions not linked to radiation-induced inflammation may not benefit from this research.

What this research studies

This project explores special lipid molecules that help resolve inflammation after radiation exposure. Researchers will study how these mediators act in the body to protect blood and tissue cells and limit long-term damage after radiation events. The work is designed to understand whether these mediators could become a treatment used alongside or instead of current supports for radiation exposure. If the approach works, it could reduce complications and improve recovery for people affected by accidental or intentional radiation exposure.

Why it matters

Potential benefit: If successful, this research could lead to a new medical option to reduce radiation-related injury and speed recovery for affected patients.

How similar studies have gone: Previous work on similar lipid-mediating pathways has shown promise in modulating inflammation, though this exact approach in radiation context is exploratory.

Where this research is happening

  • Albany Medical College
    Albany, United States
    Active

Researchers

  • Principal investigator: Macnamara, Katherine C — Albany Medical College
  • Study coordinator: Macnamara, Katherine C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.